Cargando…
Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
This study aims to investigate the clinical role of preoperative pyuria for predicting bacillus Calmette–Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC). We performed a logistic regression analysis on 453 patients with NMIBC who were treated with BCG immunotherapy after a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432248/ https://www.ncbi.nlm.nih.gov/pubmed/34501211 http://dx.doi.org/10.3390/jcm10173764 |
_version_ | 1783751121175576576 |
---|---|
author | Suh, Jungyo Yuk, Hyeong Dong Jeong, Chang Wook Kwak, Cheol Kim, Hyeon Hoe Ku, Ja Hyeon |
author_facet | Suh, Jungyo Yuk, Hyeong Dong Jeong, Chang Wook Kwak, Cheol Kim, Hyeon Hoe Ku, Ja Hyeon |
author_sort | Suh, Jungyo |
collection | PubMed |
description | This study aims to investigate the clinical role of preoperative pyuria for predicting bacillus Calmette–Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC). We performed a logistic regression analysis on 453 patients with NMIBC who were treated with BCG immunotherapy after a transurethral resection of bladder tumours, to evaluate predictive factors of BCG unresponsiveness. We also analysed univariate and multivariable survival data to estimate the prognostic impact of pyuria. Of the total study population, 37.6% (170/453) of patients had BCG unresponsiveness. A multivariable logistic regression analysis revealed that a history of upper urinary tract cancer (odds ratio (OR): 1.86, 95% confidence interval (CI): 1.04–3.32, p-value = 0.035) and the presence of pyuria (OR: 1.51, 95% CI: 1.01–2.27, p = 0.047) and tumour multiplicity (OR: 1.80, 95% CI: 1.18–2.75, p-value < 0.001) were significant predictors of BCG unresponsiveness. A Cox proportional hazards analysis model showed that pyuria was a significant prognostic factor for progression-free survival (hazard ratio: 4.51, 95% CI: 1.22–16.66, p = 0.024). A history of upper urinary tract cancer and the presence of pyuria and tumour multiplicity are predictive markers of BCG unresponsiveness. For patients with NMIBC who have preoperative pyuria, treatment using BCG should be considered cautiously. |
format | Online Article Text |
id | pubmed-8432248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84322482021-09-11 Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer Suh, Jungyo Yuk, Hyeong Dong Jeong, Chang Wook Kwak, Cheol Kim, Hyeon Hoe Ku, Ja Hyeon J Clin Med Article This study aims to investigate the clinical role of preoperative pyuria for predicting bacillus Calmette–Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC). We performed a logistic regression analysis on 453 patients with NMIBC who were treated with BCG immunotherapy after a transurethral resection of bladder tumours, to evaluate predictive factors of BCG unresponsiveness. We also analysed univariate and multivariable survival data to estimate the prognostic impact of pyuria. Of the total study population, 37.6% (170/453) of patients had BCG unresponsiveness. A multivariable logistic regression analysis revealed that a history of upper urinary tract cancer (odds ratio (OR): 1.86, 95% confidence interval (CI): 1.04–3.32, p-value = 0.035) and the presence of pyuria (OR: 1.51, 95% CI: 1.01–2.27, p = 0.047) and tumour multiplicity (OR: 1.80, 95% CI: 1.18–2.75, p-value < 0.001) were significant predictors of BCG unresponsiveness. A Cox proportional hazards analysis model showed that pyuria was a significant prognostic factor for progression-free survival (hazard ratio: 4.51, 95% CI: 1.22–16.66, p = 0.024). A history of upper urinary tract cancer and the presence of pyuria and tumour multiplicity are predictive markers of BCG unresponsiveness. For patients with NMIBC who have preoperative pyuria, treatment using BCG should be considered cautiously. MDPI 2021-08-24 /pmc/articles/PMC8432248/ /pubmed/34501211 http://dx.doi.org/10.3390/jcm10173764 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suh, Jungyo Yuk, Hyeong Dong Jeong, Chang Wook Kwak, Cheol Kim, Hyeon Hoe Ku, Ja Hyeon Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title | Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title_full | Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title_fullStr | Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title_full_unstemmed | Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title_short | Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer |
title_sort | pyuria as a predictive marker of bacillus calmette–guérin unresponsiveness in non-muscle invasive bladder cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432248/ https://www.ncbi.nlm.nih.gov/pubmed/34501211 http://dx.doi.org/10.3390/jcm10173764 |
work_keys_str_mv | AT suhjungyo pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer AT yukhyeongdong pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer AT jeongchangwook pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer AT kwakcheol pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer AT kimhyeonhoe pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer AT kujahyeon pyuriaasapredictivemarkerofbacilluscalmetteguerinunresponsivenessinnonmuscleinvasivebladdercancer |